)
Bio-Techne (TECH) investor relations material
Bio-Techne Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Merger agreement signed for acquisition by Merck KGaA, Darmstadt, Germany, with closing expected by late 2026 or early 2027, pending regulatory and shareholder approvals.
Integration planning underway, focusing on business continuity, talent retention, and leveraging combined strengths.
Until closing, both companies operate independently, with no immediate operational changes.
Forward-looking statements highlight risks including regulatory approvals, integration challenges, and market uncertainties.
Voting matters and shareholder proposals
Shareholder approval is a key closing condition for the transaction.
Proxy materials and relevant documents are filed with the SEC and available for shareholder review.
Board of directors and corporate governance
Directors and executive officers of both companies may participate in proxy solicitation.
Information on directors, governance, and compensation is available in prior proxy statements and SEC filings.
- Shareholders will vote on the Merck KGaA acquisition, with closing expected by early 2027.TECH
Proxy filing - Acquisition gains regulatory approval; shareholder vote and key risks remain.TECH
Proxy filing - Shareholders will vote on a $73/share cash acquisition, with board support and detailed executive payouts.TECH
Proxy filing - Q4 organic revenue up 3%, GAAP EPS at $0.35, and acquisition by Merck KGaA announced.TECH
Q4 2026 - Shareholders will vote on a $73.00 per share cash acquisition, with board unanimous support.TECH
Proxy filing - Shareholders to receive $73.00 per share in cash upon merger closing, expected by early 2027.TECH
Proxy filing - Strong innovation and market recovery position the business for accelerated growth by late 2026.TECH
53rd Annual Nasdaq Investor Conference - Momentum in core markets and innovation signal a return to growth and margin expansion.TECH
Stifel 2025 Healthcare Conference - Q2 organic revenue rose 9% to $297M, with strong segment growth and margin expansion.TECH
Q2 2025
Next Bio-Techne earnings date
Next Bio-Techne earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)